EZH2 and cancer: EZH2 is able to regulate several cell processes as the differentiation of hematopoietic stem and progenitor cells, immune cell development, including T, B, and natural killer cells, cell cycle progression, autophagy and apoptosis [9]; however, its overexpression or dysregulation may contribute to cancer initiation and progression [12].